General Information of Drug (ID: DMG7YNI)

Drug Name
Indatuximab ravtansine
Indication
Disease Entry ICD 11 Status REF
Multiple myeloma 2A83 Phase 2 [1]
Drug Type
Monoclonal antibody
Cross-matching ID
TTD ID
D00CQI

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)